These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. BRAF mutations in metanephric adenoma of the kidney. Choueiri TK; Cheville J; Palescandolo E; Fay AP; Kantoff PW; Atkins MB; McKenney JK; Brown V; Lampron ME; Zhou M; Hirsch MS; Signoretti S Eur Urol; 2012 Nov; 62(5):917-22. PubMed ID: 22727996 [TBL] [Abstract][Full Text] [Related]
7. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation. Kwon HJ; Kim EK; Kwak JY Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369 [TBL] [Abstract][Full Text] [Related]
8. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status. Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863 [TBL] [Abstract][Full Text] [Related]
9. BRAF and KIT somatic mutations are present in amelanotic melanoma. Massi D; Pinzani P; Simi L; Salvianti F; De Giorgi V; Pizzichetta MA; Mirri F; Steffan A; Orlando C; Santucci M; Canzonieri V Melanoma Res; 2013 Oct; 23(5):414-9. PubMed ID: 23938765 [TBL] [Abstract][Full Text] [Related]
13. Thyroid-like follicular carcinoma of the kidney: The mutational profiling reveals a BRAF wild type status. Fanelli GN; Fassan M; Dal Moro F; Soligo M; Munari G; Zattoni F; Gardiman MP; Prayer-Galetti T Pathol Res Pract; 2019 Sep; 215(9):152532. PubMed ID: 31345592 [No Abstract] [Full Text] [Related]
14. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value. Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442 [TBL] [Abstract][Full Text] [Related]
15. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights. Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma. Yaman B; Akalin T; Kandiloğlu G Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015 [TBL] [Abstract][Full Text] [Related]
18. Adult classical glioblastoma with a BRAF V600E mutation. Takahashi Y; Akahane T; Sawada T; Ikeda H; Tempaku A; Yamauchi S; Nishihara H; Tanaka S; Nitta K; Ide W; Hashimoto I; Kamada H World J Surg Oncol; 2015 Mar; 13():100. PubMed ID: 25885250 [TBL] [Abstract][Full Text] [Related]
19. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival. Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419 [TBL] [Abstract][Full Text] [Related]
20. Metanephric stromal tumor in an adult with PDGFRA mutation: a case report. Guo S; Qian H; Zhu H; Yang Y; Yang X; Sun H Diagn Pathol; 2023 Jul; 18(1):83. PubMed ID: 37454137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]